The agreement terms were not disclosed, but Genstar targets companies with $50 million to $1 billion enterprise values and annual earnings of more than $15 million.
More Articles on Orthopedic Devices:
DePuy Synthes Trauma Launches Radial Head Prosthesis
Zimmer Insider Sells 21k+ Shares
5 New Spine & Orthopedic Device Launches, Releases, Approvals
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.